TCTR20180420002已完成未知
Anticholinergic Discontinuation and Cognitive Functions in Patients with Schizophrenia: A Pharmacist †Physician Collaboration in the Outpatient Department
Siam University0 个研究点目标入组 30 人开始时间: 2018年4月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •1) aged between 18-50 years; 2) had been diagnosed of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, 4th (DSM-IV); 3) received stable agent and dosage regimen of antipsychotics for at least 2 months; 4) had mild to moderate symptoms of schizophrenia which was determined by Brief Psychiatric Rating Scale (BPRS) of 32-54; and 5) had duration of illness after diagnosis of schizophrenia less than 10 years.
排除标准
- •Patients were excluded if they had mental retardation, delirium, or had communication impairment which affected the ability to perform cognitive function tests.
研究者
相似试验
进行中（未招募）
1 期
Impact of CHOlinergic Stimulation on COgnitive and MOtor Functions and Brain Activity in Elderly Volunteers (CHOCOMO) - a randomised, placebo-controlled trialCTIS2024-512172-35-00Carl Von Ossietzky Universitaet Oldenburg50
已完成
不适用
A study of the effect of long-term anticholinergic administration -solifenacin succinateoveractive bladderJPRN-UMIN000017260Hokkaido University Graduate School of Medicine100
已完成
不适用
Evaluation of the usefulness of anti-cholinergic and B(Beta)3 agonist in patients with OAB.Overactive bladderJPRN-UMIN000008863Clinical Research Support Center Kyushu400
招募中
4 期
Anticholinergic Deprescription in SchizophreniaSchizophreniaSchizoaffective DisorderNCT06562608Deepak K. Sarpal, M.D.105
终止
不适用
Anticholinergic Burden in SchizophreniaSchizophreniform DisorderPsychotic DisordersDelusional DisorderSchizoaffective DisorderSchizophreniaNCT00715377Centre for Addiction and Mental Health2